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Inﬂammatory bowel diseaseTrillions of commensal bacteria cohabit our bodies to mutual beneﬁt. In the past several years, it has
become clear that the adaptive immune system is not ignorant of intestinal commensal bacteria, but
is constantly interacting with them. For T cells, the response to commensal bacteria does not appear
uniform, as certain commensal bacterial species appear to trigger effector T cells to reject and
control them, whereas other species elicit Foxp3+ regulatory T (Treg) cells to accept and be tolerant
of them. Here, we review our current knowledge of T cell differentiation in response to commensal
bacteria, and how this process leads to immune homeostasis in the intestine.
 2014 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
The intestines are home to hundreds of commensal bacterial
species that provide many beneﬁts to the host, including important
contributions to the metabolism of food [1]. However, as commen-
sal bacteria are foreign to the host, they can trigger unwanted
immune responses such as inﬂammatory bowel disease (IBD) [2].
Yet, the gastrointestinal tract is also an important portal for
bacterial infections. Thus, the immune systemmust protect against
pathogenic bacteria while avoiding inappropriate immune
responses to commensal bacteria.
In broad strokes, this balancing act is analogous to that
employed by the immune system to protect against infections
while avoiding autoimmunity. However, the mechanisms that pre-
vent immune responses to self-antigens may not be applicable to
commensal bacterial antigens. An important mechanism of self-
tolerance is the purging of auto-reactive cells while they are still
immature and unable to cause immunopathology. For T cells, this
occurs in the thymus, an organ that is far removed from the
intestine. Gut antigens are therefore unlikely to be present in thethymus to induce tolerance, implying that different mechanisms
are utilized to prevent unwanted T cell immune responses to com-
mensal bacteria. Here, we will review our current understanding of
T cell interactions with commensal bacteria that preserve immune
homeostasis and avoid immunopathology.2. Regulatory T cells play a crucial role in maintaining tolerance
to commensal bacteria
Although the mucosal lining of the intestine provides an impor-
tant protective barrier against commensal bacteria, it has become
clear that this barrier is imperfect, resulting in a need for immune
tolerance to gut antigens. One of the ﬁrst clues came from early
studies showing that a subset of CD4+ T cells [3], now known to
be Foxp3+ regulatory T (Treg) cells, is required to prevent other
CD4+ T cells from inducing colitis upon transfer into lymphopenic
hosts (reviewed in [2,4,5]). Subsequent studies showed that com-
mensal bacteria are important for driving intestinal pathology in
the context of Treg cell deﬁciency. For example, ablation of IL-2
leads to a loss of Treg cell number and function, which results in
a variety of immunopathology [6]. However, only colitis ismarkedly
reduced in germ-free (GF) IL-2-deﬁcient mice [7–9]. Similarly, GF
conditions limit colitis, but not other inﬂammatory manifestations,
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or with T cell deletion of Uhrﬂ (Ubiquitin-like, with pleckstrin-
homology and RING-ﬁnger domains 1), an epigenetic regulator
that facilitates colonic Treg proliferation and maturation [11]. As
memory T cells from conventionally housed mice are more efﬁ-
cient at inducing colitis [12], these data suggest that Treg cells
act to restrain normal effector responses to commensal bacteria.
Thus, Treg cells are important in establishing a tolerogenic
environment to maintain immune homeostasis to commensal
bacteria in the intestine.
Substantial progress has been made in the past several years
regarding the origin and speciﬁcity of Treg cells involved in intes-
tinal tolerance. Although it is still debated [13], several lines of evi-
dence suggest that colonic Treg cells arise primarily from
peripheral Treg cell differentiation from naive T cells (pTreg,
[14,15]), as opposed to arising from the thymus during T cell devel-
opment (tTreg, [16,17]). First, adoptive transfer of naive T cells into
normal hosts suggested that the intestines are sites that facilitate
peripheral Treg cell selection [18]. Second, markers that may dis-
tinguish thymic Treg cells such as high expression of Helios or
Neuropilin-1 (Nrp-1) imply that 80% of colonic Treg cells arise
from peripheral selection [19–21]. Third, one T cell receptor
(TCR) repertoire study suggested that most colonic Treg TCRs do
not facilitate thymic Treg cell selection [22]. Fourth, a study of
Foxp3-deﬁcient mice devoid of Treg cells revealed that adoptive
transfer of natural Treg cells was not sufﬁcient to restore immune
homeostasis, and required transfer of Foxp3 cells capable of
undergoing peripheral Treg cell selection [23]. Finally, studies of
the Foxp3 locus revealed that mice deﬁcient in conserved non-cod-
ing sequence-1 (CNS-1) had fewer Treg cells in the intestine, which
was correlated with a defect in peripheral Treg cell selection
[24,25]. Taken together, these data support an important role for
peripheral Treg cell selection in the gut.
However, other reports have argued against this interpretation.
For example, the sensitivity and speciﬁcity of markers of thymic
versus peripheral Treg cell selection such as Helios has been called
into question [23,26,27]. Moreover, a different TCR repertoire
study suggested that most colonic Treg cells are of thymic origin
based on cross-referencing TCR sequences [28]. While future
experiments are required to determine the exact proportions of
pTreg versus tTreg in the colon, it is clear that the intestines are
enriched in pTreg cells relative to other tissues in the body.
In regards to the antigen speciﬁcity of colonic Treg cells, recent
studies suggest that they are often reactive to commensal bacte-
ria. First, several studies reported that some, but not all, bacterial
species can increase the frequency of Treg cells in the gut. For
example, Clostridium clusters XlVa and IV [21,29] or altered
Schaedler ﬂora (ASF) [30] introduced into GF mice markedly
increased the frequency of colonic Treg cells. Lactobacillus reuteri
[31] has also been associated with increased Treg cell percentage
in the intestines. Second, analyses of TCR repertoires suggested
that a substantial fraction and perhaps the majority of colonic
Treg TCRs recognize commensal bacterial antigens. Since the
TCR repertoire is extremely complex, mice with limited TCR
repertoires were used to assess the colonic Treg TCR repertoire
[22,28]. In these studies, it was observed that colonic Treg cells
utilized TCRs that were different than those used by Treg cells
in other tissues or secondary lymphoid organs [22]. Further
analysis of colonic Treg TCRs revealed direct recognition of
antigens present in colonic contents, or in several cases, individual
bacterial isolates [22,28]. Consistent with TCR recognition of
commensal bacterial antigens, antibiotic treatment could
markedly change the colonic Treg repertoire [28], Taken together,
this body of evidence strongly suggests that commensal bacteria
routinely trigger antigen speciﬁc Treg cell responses.3. Mechanisms that facilitate Treg cell selection in the gut
The enhancement in peripheral Treg cell selection to commen-
sal bacteria may result from a number of mechanisms (Fig. 1). First,
antigen presenting cell (APC) subsets in the intestine such as
CD103+ dendritic cells (DCs) have been reported to favor Treg cell
selection, as they express higher levels of retinal dehydrogenase
(RALDH) to produce the vitamin A metabolite retinoic acid (RA)
[18,32,33]. RA may inhibit effector cell cytokine production [34],
as well as act directly on T cells [35] to promote Treg cell selection.
Moreover, CD103+ DCs can generate transforming growth factor b
(TGFb) that acts in concert with RA to induce Treg cells [36].
Finally, it has been reported that these DC functions may be related
to WNT/b-catenin signals that are delivered to intestinal, but not
splenic DCs [37].
What might be the signals localized to the gut that promote
these DCs to facilitate Treg cell selection? One recent report
suggested that mucus from the intestinal lumen itself can activate
tolerogenic pathways in DCs by triggering WNT signaling via
b-catenin [38]. Mucus triggered WNT-signaling might be predicted
to affect only the subset of DCs close to the mucosal surface.
However, a TCF reporter of WNT signaling suggests that intestinal
DCs receive a fairly uniform degree of WNT signaling [37]. Future
studies are required to address the relative contributions of mucus
versus other sources of WNT signaling in intestinal DCs.
Another potential intestinal signal for Treg cell selection may
come from the microbiota itself. Short-chain fatty acids (SCFAs)
arising from bacterial fermentation can act on DCs to promote tol-
erance [39–41]. SCFAs may also act directly on T cells themselves
to promote colonic Treg cell expansion [42]. Another bacterial
product that can affect Treg cells is polysaccharide A (PSA) from
Bacteroides fragilis (B. fragilis), which triggers toll-like receptor
(TLR) 2 on Treg cells to induce IL-10 production [43]. Thus,
commensal bacteria themselves provide potent signals that are
interpreted by the intestinal immune system to facilitate tolerance.4. Effector cell generation to commensal bacteria
Despite the plethora of intestinal factors that favor Treg cell dif-
ferentiation or expansion, Treg cells represent only 20–40% of CD4+
T cells in the colon. Effector cells therefore represent the dominant
T cell population within the intestine during homeostasis [44,45].
The generation of effecter T cell subsets in the intestine has been
associated with signals derived from commensal bacteria, as GF
mice harbor fewer Th1 and Th17 cells compared to conventionally
housed mice [12,46]. Also, DNA from gut bacteria plays an impor-
tant role in the induction of gut resident Th1 and Th17 cells at
steady state through the engagement of TLR9 [47]. Thus, the
generation of intestinal effector T cell population is clearly
inﬂuenced by the commensal bacteria.
It is less clear, however, whether intestinal effector T cells rec-
ognize commensal bacterial antigens. Indirect support comes from
the observation that effector T cells induced in the presence of
commensal bacteria are more efﬁcient at inducing colitis than cells
from GF mice [12]. However, this does not necessarily mean that
effector cells are speciﬁc to commensal bacteria, as bacterial
products may also cause antigen-non-speciﬁc changes in the envi-
ronment that affect T cell trafﬁcking, differentiation, and function.
Direct support for commensal-speciﬁc effector cell generation
comes from murine studies of Th17 cells, which were shown to
be critically dependent on a single bacterial species-segmented
ﬁlamentous bacteria (SFB) [48]. SFB is a spore-forming Gram-
positive anaerobe residing primarily in the terminal ileum that
makes intimate interaction with the mucosal barrier through tight
Fig. 1. Mechanisms that facilitate Treg cell selection in the gut. Commensal bacteria can promote the induction of Treg cells via direct sensing of microbial products through
TLRs or metabolites such as SCFAs. Commensals or SCFAs can also induce tolerogenic DCs that favor Treg cell differentiation through the production of RA and TGF-b. Mucus
and intestinal WNT can also trigger a b-catenin dependent tolerogenic program in DCs. The sites of interactions are not speciﬁed in this ﬁgure, but may be in the mesenteric
lymph nodes.
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of SFB compared with other commensal bacteria that may underlie
its ability to elicit Th17 cells. Recently, it was shown that the
majority of Th17 cells are speciﬁc to SFB antigens [49,50], suggest-
ing that SFB provides both the dominant T cell epitopes as well as
signals that facilitate Th17 differentiation. Thus, both Treg and
effector cells can be elicited to commensal bacteria.
5. Effector versus regulatory T cell selection
The induction of both Treg and effector cells by commensal bac-
teria raises a fundamental question as to how the immune system
determines Treg versus effector cell selection to bacterial antigens.Available data suggests that this is not a stochastic process, but
may be instructed by speciﬁc bacterial species. For example,
Th17 selection to SFB is not accompanied by Treg selection, as
SFB-speciﬁc TCR transgenic cells become mostly RORct+ and not
Foxp3+ cells [49]. Similarly, it has been reported that CD44hi effec-
tor T cells utilize different TCRs than Treg cells [22], indicating cell-
fate determination based on TCR speciﬁcity.
The usage of different TCRs between Treg and effector cells
could suggest that a biophysical property of TCR interaction with
peptide:MHC, such as afﬁnity or the amount of antigen, may deter-
mine peripheral T cell selection [51,52]. In addition, recent studies
indicate that environmental factors contribute to peripheral T cell
differentiation to commensal bacteria. For example, SFB-speciﬁc
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when their cognate antigen is expressed by Listeria and not SFB
[49]. Moreover, TCR transgenic cells speciﬁc for the commensal
CBir1 ﬂagellin antigen adopt a Th1 phenotype upon infection with
Toxoplasma gondii (T. gondii), but a Th17 phenotype after dextran
sodium sulfate (DSS) injury [53]. Although studies of Treg versus
effector cell differentiation to commensal bacteria are currently
unavailable, OT-II TCR transgenic cells undergo peripheral Treg cell
development in response to oral feeding of cognate antigen
[18,54], whereas they undergo effector cell generation in the con-
text of infection [55]. Therefore, TCR afﬁnity for antigen, antigen
dose, and the cytokine milieu may all contribute to the signals that
direct T cell lineage commitment.
Innate stimulators from commensal bacteria may direct T cell
differentiation via selective activation of cytokine production from
APCs by TLRs, which are important sensors that recognize
conserved molecular motifs on bacteria. TLRs have been suggested
to promote pro-inﬂammatory effector responses. For instance,
mice deﬁcient in MyD88 (Myeloid differentiation primary
response gene 88), an important signaling component for many
TLRs, are relatively resistant to intestinal inﬂammation resulting
from Treg cell [56] or IL-10 [57] deﬁciency. Consistent with these
observations, TLR9 sensing of commensal DNA has been suggested
to favor intestinal effector (Th1/Th17) rather than Treg
development [47]. However, a role for TLRs in Treg selection has
also been suggested. TLR2 signaling has been reported to induce
IL-10 and RA to promote Treg cell selection [58]. DNA of the
probiotic Lactobacillus species is enriched in suppressive motifs
that signal through TLR9 to prevent DC activation and maintain
Treg-cell conversion during inﬂammation [59]. Moreover, B. fragilis
PSA can trigger TLR2 signaling on Treg cells to induce IL-10 expres-
sion and promote tolerance [43]. One explanation for some of these
contrasting reports is that TLRs are found on many cell types and
contribute to facets of intestinal homeostasis not directly related
to T cell differentiation signals, including epithelial integrity [60].
Thus, while it is likely that TLRs play an important role in T cell
responses to commensal bacteria, their precise function in deter-
mining peripheral T cell differentiation to speciﬁc bacterial species
remains to be determined.
APC subsets have also been implicated in Treg versus effecter
cell determination [61,62]. Lamina propria DC subsets may provide
different cytokine environments that favor Treg versus Th17 selec-
tion. As discussed above, CD103+ DCs have been suggested to favor
Treg cell selection via production of RA and TGFb [18,32,33]. Inter-
estingly, the CD11b+ subset of CD103+ DCs have been found to be
potent producers of IL-6 and IL-23 that favor Th17 differentiation
[47,63,64]. Consistent with these observations, genetic depletion
of the CD103+CD11b+ DC subset showed a decrease in Th17 cells
[64–66], whereas depletion of both CD11b+ and CD11b subsets
of CD103+ DCs were required to see a decrease in the number of
Treg cells [65]. However, it is unclear whether the impact on the
number of Th17 versus Treg cells is related to speciﬁc response to
bacteria species or global effects on the overall cytokine environ-
ment, as the decreased number of Th17 cells was independent of
MHC II expression on the CD103+CD11b+ cells [65].
Other types of APC have also been described to be involved in
gut homeostasis [67]. Macrophages, perhaps via cytokine produc-
tion, can affect the regulatory to effector cell balance in the gut
[68,69]. Recently, another cell type in addition to the traditional
APCs (DCs and macrophages) has been suggested to perform an
antigen presenting role in the gut. Innate lymphoid cells (ILCs)
were recently shown to express MHC II and negatively regulate
CD4+ T cell responses [70]. However, instead of inducing Treg cells,
it was suggested that ILC antigen presentation inhibits the differ-
entiation of effector T cells via an unknown mechanism.In summary, there are many parameters that can control T cell
differentiation to commensal bacteria. There are global factors
such as SCFAs, WNT, TGFb, and RA that favor Treg cell selection.
There are local factors such as TLR ligands, access to mucus, and
different APC subsets that differentially favor Treg versus effector
cell selection. Moreover, it is possible that some global factors
are also modulated at the local level, and vice versa. Anatomic
factors, such as small intestine versus colon may also play a role
by affecting the resident bacterial constituents (e.g. SFB is mostly
ileal), mucus amount and composition, mucosal barrier function,
and APC types. Thus, much remains to be discovered regarding
how individual commensal bacterial species trigger the speciﬁc
mechanisms that determine Treg versus effector T cell
differentiation.
6. Effector versus regulatory T cell function during homeostasis
During homeostasis, both regulatory and effector T cells with
differing antigen speciﬁcities are generated to commensal bacteria.
While thymically-derived Treg cells are likely to be involved at
some level in intestinal tolerance to commensal bacteria [28], their
functional role has not been clearly established. However, the
importance of peripheral Treg cell selection in maintaining toler-
ance to commensal bacteria is supported by the aforementioned
studies of T cell transfers into Foxp3-deﬁcient mice [23], as well
as studies of CNS-1-deﬁciency in the Foxp3 locus [24].
By contrast, the role of effector T cells in gut homeostasis to
commensal bacteria has been more difﬁcult to demonstrate.
One hypothesis is that effector T cells represent an active immune
response against certain commensal bacterial species. For
example, it has been shown that CD4 T cells are required in the
regulation of IgA production, and thus indirectly prevent bacterial
translocation in mice lacking junctional adhesion molecule A
(JAM-A, encoded by F11r) [71]. Similarly, the aberrant expansion
of SFB in IgA deﬁcient mice suggests that adaptive immunity can
restrain certain commensal bacteria [72]. Other examples come
from studies of innate cells, where depletion of ILCs revealed a
marked dissemination and systemic infection of commensal
bacteria Alcaligenes [73]. Furthermore, absence of T-bet, a
transcription factor important for Th1 type responses, in innate
cells in T and B cell-deﬁcient mice results in loss of commensal
bacterial control and inﬂammation [74]. However, T-bet deﬁ-
ciency in mice with T and B cells does not result in spontaneous
colitis [74]. Similarly, spontaneous pathology has not been
reported for mice deﬁcient in the signature Th17 cytokine, IL-17
[75] or transcription factor RORct [76]. Thus, effector T cells,
perhaps via induction of IgA, may act to constrain certain species,
but do not appear required for preventing large scale invasion by
commensal bacteria during homeostasis.
Another possibility is that effector T cells have no major role in
homeostasis, and are byproducts of an immune system that cannot
perfectly determine whether each bacterial epitope is associated
with a benign versus pathogenic bacteria [77,78]. This is reminis-
cent of the observation that some self-reactive cells do escape
thymic tolerance mechanisms that induce deletion or tTreg cell
selection. While these autoreactive escapees of thymic selection
appear quiescent during homeostasis, their pathogenic potential
can be revealed after adoptive transfer into lymphopenic hosts
[79] or Treg cell depletion [80].
A third possibility is that effector T cells to commensal bacteria
exist to prime the immune system against pathogens. For example,
mice harboring SFB are more resistant to Citrobacter rodentium
infection [48]. However, it remains possible that commensal
bacteria can inﬂuence ILCs or other innate immune cells in addi-
tion to altering the effector T cell population. Thus, a clear role
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remains to be established.
7. T/B collaboration in response to commensal bacteria
The data discussed above suggests that both effector and regu-
latory T cells routinely interact with commensal bacteria under
homeostatic conditions [45]. Similarly, the B cell arm of the
adaptive immune system has also been found to interact with
commensal bacteria during homeostasis [81,82], with the majority
of B cells in gut associated lymphoid tissue (GALT) directed
towards bacterial antigens [83]. As suggested by a study of a com-
mensal species Bacteroides thetaiotaomicron [84], IgA may limit the
ability of commensal bacteria to trigger an inﬂammatory response.
Although T cell help is not essential for IgA class switching in
the intestines [85], it appears that the paradigm of T cell help for
B cells is applicable to intestinal IgA production during homeo-
static conditions, as the presence of T cells is important for gener-
ating somatic hypermutation [86]. Moreover, TCR transgenic cells
speciﬁc to a commensal bacterial ﬂagellin antigen CBir1 induce
IgA to that antigen [87]. Thus, these data suggests that commensal
bacterial antigens are presented to both the B and T cell arms of the
adaptive immune system during homeostasis.
One interesting observation from the TCR transgenic experi-
ments was that depletion of Treg cell using anti-CD25 lead to a
decrease in anti-CBir1 IgA, suggesting that Treg cells provide help
for B cells [87]. Foxp3+ Treg cells have been reported to convert
to follicular B helper T cells (Tfh) in lymphopenic settings [88].
However, an alternative possibility is that CD25 depletion may also
affect effector cells. Additionally, Treg cells have also been reported
to convert into follicular regulatory T cells (Tfr) [89,90], which lack
CD40L expression and instead secrete IL-10 and may act to inhibit,
rather than provide, T:B collaboration. Thus, it remains unclear
whether Treg cells, perhaps via transdifferentiation into other T
cell subsets, provide T cell help for B cells.
Th17 cells appear to be an important source of B cell help, as
large numbers of both antigen speciﬁc and non-speciﬁc Th17 cells
were reported to migrate to B cell germinal centers in the diffuse
lamina propria during SFB colonization [91]. Other groups utilized
cell fate reporters have shown that Th17 cells can also convert to
Tfh cells in the gut [92]. However, as Th17 cells have not been
reported to be readily induced to bacterial species other than
SFB, the mechanism of T cell help for IgA class switching and afﬁn-
ity maturation that react to the rest of the microbiota remains
unclear.
8. Are adaptive immune responses to commensal bacteria
dynamically regulated?
An intriguing observation regarding IgA produced in response
to commensal bacteria is that it appears to be dynamically regu-
lated [93]. While colonization of GF mice with one species resulted
in a speciﬁc and long-lived IgA response, this response was lost
with the addition of other commensals. Moreover, repeated expo-
sure to the commensal did not result in the booster effect that
might be expected based on the classic immunization paradigm.
These data suggest that IgA responses to commensal bacteria
may not ﬁt the pattern of classic long lived plasma cells that can
last the life of an individual, but rather are dynamically regulated
by the current commensal bacterial population.
Indeed, there are other peculiarities of the GALT B cell biology
that distinguishes the IgA response from a typical systemic B cell
response. For example, mucosal associated IgA plasma cells do
not seem to home to the bone marrow (BM), and are instead
retained in the gut, where APRIL- (a proliferation inducing ligand)secreting neutrophils have been suggested to aid in B cell mainte-
nance and survival [94]. Additionally, gut IgA plasma cells, unlike
BM plasma cells, retain functional B cell receptors on their surface
[95], which may provide survival signals in lieu of BM stroma-
derived cytokines. Whether these differences in IgA B cell biology
account for the dynamic nature of IgA responses to commensals
is unclear.
An intriguing question is whether all adaptive immune
responses to commensal bacteria are dynamic and relatively short
lived. Treg cells have been suggested to be regulated by the
amount of self-antigens, as the Treg TCR repertoire changes with
the anatomic location of secondary lymphoid organs [96,97].
Similarly, the number of small intestinal Th17 cells has been
shown to decrease when the mice are treated with vancomycin,
an antibiotic that kills SFB [98]. When SFB is reintroduced, Th17
numbers go up, consistent with dynamic regulation of the T cell
population. These observations in Treg and Th17 cells support
the notion that continual competition for antigen may drive the
intestinal immune system. This does not preclude the possibility
that T cell memory can co-exist with dynamic regulation, as strong
responses may elicit memory in the effector [53,99] and regulatory
T cell population [100].
In addition to the provision of antigens that maintain T cell
‘‘ﬁtness’’, commensal bacteria may also tune the T cell population
through other factors. For example, it has been shown that com-
mensal bacteria-stimulated IL-23 [101] and IL-15 [102] promote
inﬂammatory T cell responses. Similarly, RA was required to elicit
proinﬂammatory T cell responses to infection and mucosal vacci-
nation [103]. In addition, IL-12 can enhance the antigen respon-
siveness of T cells to sustain an ongoing autoimmune responses
[104]. Finally, mice with intestinal epithelial cell-speciﬁc deﬁ-
ciency of caspase-8 or FADD (Fas-Associated protein with Death
Domain) have been shown to spontaneously develop terminal ile-
itis or colitis associated with loss of Paneth cell and epithelial cell
necrosis [105,106]. In these mice, commensal bacteria-induced
TNF-a trigger the programmed necrosis of intestinal epithelial cells
which drives the inﬂammatory response and epithelial inﬂamma-
tion. In aggregate, these data suggest that the T cell population is
also dynamically tuned by antigen-independent factors elicited
by commensal bacteria.
Why might dynamic regulation of adaptive immunity to com-
mensal bacteria occur? One possibility is that pathogenic bacteria
are encountered episodically, requiring memory, whereas com-
mensal bacteria are always in contact with the host. A dynamically
regulated Treg cell population would be tuned to the current
commensal microbiota and be more responsive to a large inﬂux
of commensal antigens from mucosal injury, thereby limiting
effector T cell activation and excessive inﬂammation. By contrast,
bacteria that are new to the intestinal tract would not trigger
pre-existing Treg or effector T cells, but require de novo selection
of effector versus regulatory T cell responses. This would allow
more rapid effector responses to pathogens and limit the buildup
of effector T cells responsive to commensal bacteria that might
trigger IBD. Future experiments are required to address the
conjecture that T cell responses to commensal bacteria are amnes-
tic and dynamically regulated by clonal competition for antigen.
9. How is tolerance to commensal bacteria broken?
For most individuals, tolerance to commensal bacteria remains
intact throughout their lifetime. However, approximately 0.44%
of individuals break tolerance and develop IBD [107]. Genome
wide association studies (GWAS) have clearly identiﬁed a number
of genetic risk factors for IBD that affect intestinal epithelial func-
tion, general immune regulation, and innate immune function
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bacterial translocation or outgrowth, triggering an inﬂammatory
response from otherwise normal T cells. Defects in T cell related
genes, such as HLA, suggest that T cell interactions with commen-
sal bacteria may also be abnormal in IBD [108]. Thus, breakage in
T cell tolerance to commensal bacteria could include a primary
T cell defect or arise secondary to other perturbations of intestinal
immune homeostasis.
In addition to genetic factors, an intriguing question is whether
environmental insults can break tolerance. This is suggested by the
observation that IBD is increasing in geographic areas such as
North America [107]. An increased risk of IBD has also been asso-
ciated with recent gastrointestinal infections [110]. While com-
mensal bacterial exposure during mucosal breaches may be
reduced by a containment structure referred to as intraluminal cast
comprised of monocytes and neutrophils [111], intestinal infec-
tions can expose the immune system to a variety of commensal
bacteria [112]. Moreover, gut infections are associated with dysbi-
osis with signiﬁcant shifts in microbiota composition. For example,
c-proteobacteria can become dominant due to their ability to thrive
under inﬂammatory condition [113,114]. Thus, infection may
result in the exposure to the immune system of previously encoun-
tered commensals as well as those that typically do not have access
during homeostasis.
A recent study convincingly showed that exposure of commen-
sals to the immune system can occur during mucosal breaches
[53]. They used CBir TCR transgenic T cells that recognize ﬂagellin
expressed by certain commensals including the Clostridium cluster
XIV class of bacteria. Interestingly, these T cells typically possess a
naïve phenotype during homeostasis, suggesting that they are not
routinely exposed to antigen. However, barrier breach results in
their development into Th1 cells during a highly Th1 polarizing
T. gondii infection, or Th17 cells after DSS administration. These T
cells persist long term in both the intestinal and secondary lym-
phoid tissues, and respond like memory T cells upon rechallenge.
Although physical segregation between the microbiota and
immune system is rapidly restored after resolution of infection,
the long-term presence of commensal-speciﬁc memory T cells
may fundamentally alter the balance of tolerance. One could spec-
ulate that over time, multiple infections may lead to the expansion
of commensal-bacteria reactive effector T cells, potentially leading
to a feed-forward loop in which these T cells can themselves over-
whelm Treg cells and cause enough inﬂammation to lead to barrier
breach and further antigen presentation [115]. This could create a
chronic and self-sustaining inﬂammatory state, perhaps culminat-
ing in IBD.
And yet, intestinal infections associated with diarrhea are com-
mon and often do not trigger IBD [110,116]. Nor do other intestinal
disorders such as diverticulitis or appendicitis that might be
predicted to result in increased exposure to commensal bacteria.
Perhaps the experience with CBir is not representative of most T
cell responses during infection as its antigen is not constitutively
presented to the immune system. Antigens that are constitutively
presented may have already triggered the appropriate effector or
regulatory T cell response. Additionally, the CBir antigen is ﬂagel-
lin, a TLR5 ligand, and may not be representative of most commen-
sal bacterial ligands. Thus, it remains unclear the extent that
infection or other injuries that result in mucosal barrier breakdown
affects the balance between effector and regulatory T cell
responses to commensal bacteria.
10. Summary
Recent work has demonstrated that the adaptive immune
system has continuous interactions with commensal bacteria toinduce both regulatory and effector T cells that promote tolerance
and immunity, respectively. The differences in the Treg versus
effector cell TCR repertoires suggest that these T cell populations
perform unique functions to maintain host health. However, many
questions remain. What are the mechanisms by which the immune
system determines regulatory versus effector cell differentiation?
How is this affected by infections or other diseases of the intestinal
tract? What is the role of effector cells in maintaining a healthy
immune environment? Addressing these questions is of consider-
able interest to understanding the fundamental immunologic
question of how we establish immune tolerance to foreign anti-
gens, but also raises the possibility that such knowledge may be
useful for the treatment or prevention of IBD or other allergic
and autoimmune diseases of the intestines.Acknowledgments
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